Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients

被引：3

作者：

Mao, Ziling ^{[1
,2
]}

Baker, Jacqueline Roshelli ^{[1
]}

Takeuchi, Masayoshi ^{[3
]}

Hyogo, Hideyuki ^{[4
,5
]}

Tjonneland, Anne ^{[6
,7
]}

Eriksen, Anne Kirstine ^{[6
]}

Severi, Gianluca ^{[8
,9
]}

Rothwell, Joseph ^{[8
]}

Laouali, Nasser ^{[8
]}

Katzke, Verena ^{[10
]}

Kaaks, Rudolf ^{[10
]}

Schulze, Matthias B. ^{[11
,12
]}

Palli, Domenico ^{[13
]}

Sieri, Sabina ^{[14
]}

de Magistris, Maria Santucci ^{[15
]}

Tumino, Rosario ^{[16
]}

Sacerdote, Carlotta ^{[17
]}

Derksen, Jeroen W. G. ^{[18
]}

Gram, Inger T. ^{[19
]}

Skeie, Guri ^{[19
]}

Sandanger, Torkjel M. ^{[19
]}

Quiros, Jose Ramon ^{[20
]}

Crous-Bou, Marta ^{[21
,22
]}

Sanchez, Maria-Jose ^{[23
,24
,25
,26
]}

Amiano, Pilar ^{[25
,27
,28
]}

Colorado-Yohar, Sandra M. ^{[25
,29
,30
]}

Guevara, Marcela ^{[25
,31
,32
]}

Harlid, Sophia ^{[33
]}

Johansson, Ingegerd ^{[34
]}

Perez-Cornago, Aurora ^{[35
]}

Freisling, Heinz ^{[36
]}

Gunter, Marc ^{[36
]}

Weiderpass, Elisabete ^{[37
]}

Heath, Alicia K. ^{[38
]}

Aglago, Elom ^{[38
]}

Jenab, Mazda ^{[36
]}

Fedirko, Veronika ^{[1
,39
]}

机构：

[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA

[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA

[3] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kanazawa, Ishikawa, Japan

[4] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan

[5] Lifecare Clin Hiroshima, Hiroshima, Japan

[6] Danish Canc Soc Res Ctr, Diet Canc & Hlth, Copenhagen, Denmark

[7] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark

[8] Univ Paris Saclay, Exposome & Hered Team, Ctr Epidemiol & Populat Hlth, UVSQ,Inserm,U1018, Villejuif, France

[9] G Parenti Univ Florence, Dept Stat, Comp Sci Applicat, Florence, Italy

[10] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[11] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany

[12] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany

[13] Inst Canc Res Prevent & Clin Network ISPRO, Canc Risk Factors & Life Style Epidemiol Unit, Florence, Italy

[14] Fdn IRCCS, Epidemiol & Prevent Unit, Ist Nazl Tumori Milano Via Venezian, Milan, Italy

[15] Azienda Osped Univ Federico II, Naples, Italy

[16] AIRE ONLUS, Hyblean Assoc Epidemiol Res, Ragusa, Italy

[17] Citta Salute & Sci Univ Hosp, Unit Canc Epidemiol, Turin, Italy

[18] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[19] UiT The Arctic Univ Norway, Dept Community Med, Tromso, Norway

[20] Publ Hlth Directorate, Asturias, Spain

[21] Bellvitge Biomed Res Inst IDIBELL, Unit Nutr & Canc, Canc Epidemiol Res Program, Catalan Inst Oncol, Barcelona, Spain

[22] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[23] Escuela Andaluza Salud Publ, Granada, Spain

[24] Inst Invest Biosanitaria Ibs Granada, Granada, Spain

[25] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain

[26] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain

[27] Minist Hlth Basque Govt, Sub Directorate Publ Hlth & Addict Gipuzkoa, San Sebastian, Spain

[28] Biodonostia Hlth Res Inst, Epidemiol Chron & Communicable Dis Grp, San Sebastian, Spain

[29] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain

[30] Univ Antioquia, Natl Fac Publ Hlth, Res Grp Demog & Hlth, Medellin, Colombia

[31] Navarra Publ Hlth Inst, Pamplona, Spain

[32] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain

[33] Umea Univ, Dept Radiat Sci, Umea, Sweden

[34] Umea Univ, Dept Odontol, Umea, Sweden

[35] Univ Oxford, Nuffield Dept Populat Hlth, Med Sci Div, Canc Epidemiol Unit, Oxford, England

[36] World Hlth Org IARC WHO, Sect Nutr & Metab, Nutr Epidemiol Grp, Int Agcy Res Canc, Lyon, France

[37] Int Agcy Res Canc IARC WHO, Off Director, Lyon, France

[38] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[39] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

INTERNATIONAL JOURNAL OF CANCER | 2023年 / 152卷 / 11期

关键词：

advanced glycation end products; colorectal cancer; glyceraldehyde-derived advanced glycation end products; mortality; prospective study; TOXIC AGES TAGE; METABOLIC SYNDROME; RECEPTOR; INFLAMMATION; ASSOCIATION; GROWTH; CELLS; COMPLICATIONS; INDIVIDUALS; INVOLVEMENT;

D O I：

10.1002/ijc.34449

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for associations of circulating glycer-AGEs concentrations with CRC-specific and all-cause mortality among 1034 colorectal cancer (CRC) cases identified within the European Prospective Investigation into Cancer and Nutrition (EPIC) study between 1993 and 2013. During a mean of 48 months of follow-up, 529 participants died (409 from CRC). Glycer-AGEs were statistically significantly positively associated with CRC-specific (HRQ5 vs Q1 = 1.53, 95% CI: 1.04-2.25, P-trend = .002) and all-cause (HRQ5 vs Q1 = 1.62, 95% CI: 1.16-2.26, P-trend < .001) mortality among individuals with CRC. There was suggestion of a stronger association between glycer-AGEs and CRC-specific mortality among patients with distal colon cancer (per SD increment: HRproximal colon = 1.02, 95% CI: 0.74-1.42; HRdistal colon = 1.51, 95% CI: 1.20-1.91; P-effect modification = .02). The highest HR was observed among CRC cases in the highest body mass index (BMI) and glycer-AGEs category relative to lowest BMI and glycer-AGEs category for both CRC-specific (HR = 1.78, 95% CI: 1.02-3.01) and all-cause mortality (HR = 2.15, 95% CI: 1.33-3.47), although no statistically significant effect modification was observed. Our study found that prediagnostic circulating glycer-AGEs are positively associated with CRC-specific and all-cause mortality among individuals with CRC. Further investigations in other populations and stratifying by tumor location and BMI are warranted.

引用

页码：2257 / 2268

页数：12

共 50 条

[31] Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products
Watanabe, Makoto
Kawai, Yasuyuki
Kitayama, Michihiko
Akao, Hironubu
Motoyama, Atsushi
Wakasa, Minoru
Saito, Ryuhei
Aoki, Hirofumi
Fujibayashi, Kousuke
Tsuchiya, Taketsugu
Nakanishi, Hiroaki
Saito, Kazuyuki
Takeuchi, Masayoshi
Kajinami, Kouji
JOURNAL OF CARDIOLOGY, 2017, 69 (3-4) : 625 - 631
[32] Comment on “dietary intake of advanced glycation end products (AGEs) and mortality among individuals with colorectal cancer”
Lian Liu
Nicole Tonya Erickson
Current Medicine, 1 (1):
[33] Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
Jiao, Li
Taylor, Philip R.
Weinstein, Stephanie J.
Graubard, Barry I.
Virtamo, Jarmo
Albanes, Demetrius
Stolzenberg-Solomon, Rachael Z.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1430 - 1438
[34] Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products
Ooi, Hayahide
Nasu, Ryuto
Furukawa, Ayako
Takeuchi, Masayoshi
Koriyama, Yoshiki
FRONTIERS IN PHARMACOLOGY, 2022, 13
[35] Slot Blot Analysis of Intracellular Glyceraldehyde-Derived Advanced Glycation End Products Using a Novel Lysis Buffer and Polyvinylidene Difluoride Membrane
Takata, Takanobu
Murayama, Hiroki
Masauji, Togen
BIO-PROTOCOL, 2024, 14 (14):
[36] GLYCERALDEHYDE-DERIVED ADVANCED GLYCATION END PRODUCTS DECREASE WHITE ADIPOSE TISSUE WEIGHT AND DOWNREGULATE LEPTIN, ADIPONECTIN, AND MACROPHAGE MARKER.
Watanabe, H.
Yoshida, Y.
Hayase, F.
MAILLARD REACTION: INTERFACE BETWEEN AGING, NUTRITION AND METABOLISM, 2010, : 51 - +
[37] Glyceraldehyde-derived advanced glycation end-products are associated with left ventricular ejection fraction and brain natriuretic peptide in patients with diabetic adverse cardiac remodeling
Yasuda, Yuushi
Aoki, Hirofumi
Fujita, Wataru
Fujibayashi, Kousuke
Wakasa, Minoru
Kawai, Yasuyuki
Nakanishi, Hiroaki
Saito, Kazuyuki
Takeuchi, Masayoshi
Kajinami, Kouji
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2022, 56 (01) : 208 - 216
[38] RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
Jun-ichi Takino
Takuma Sato
Takumi Kanetaka
Kasumi Okihara
Kentaro Nagamine
Masayoshi Takeuchi
Takamitsu Hori
Scientific Reports, 11
[39] Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography
Tahara, Nobuhiro
Yamagishi, Sho-ichi
Takeuchi, Masayoshi
Honda, Akihiro
Tahara, Atsuko
Nitta, Yoshikazu
Kodama, Norihiro
Mizoguchi, Minori
Kaida, Hayato
Ishibashi, Masatoshi
Hayabuchi, Naofumi
Matsui, Takanori
Imaizumi, Tsutomu
DIABETES CARE, 2012, 35 (12) : 2618 - 2625
[40] RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
Takino, Jun-ichi
Sato, Takuma
Kanetaka, Takumi
Okihara, Kasumi
Nagamine, Kentaro
Takeuchi, Masayoshi
Hori, Takamitsu
SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 →